One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapiesWONG, W. M; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 4, pp 793-798, issn 0269-2813Article

Identification of human, rat and mouse nocistatin in brain and human cerebrospinal fluidLEE, T.-L; FUNG, F. M. Y; CHEN, F.-G et al.Neuroreport (Oxford). 1999, Vol 10, Num 7, pp 1537-1541, issn 0959-4965Article

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in chinese patients. CommentaryNYREN, O; WONG, W. M; HU, W. H. C et al.Gut. 2002, Vol 51, Num 4, pp 464-465, issn 0017-5749, 7 p.Article

One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistanceWONG, B. C. Y; WONG, W. M; LAU, G. K. K et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 3, pp 403-409, issn 0269-2813Article

Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong KongXIA, B; XIA, H. H. X; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2005, Vol 22, Num 3, pp 243-249, issn 0269-2813, 7 p.Article

Optimal serological tests for the detection of Helicobacter pylori infection in the Chinese populationXIA, H. H.-X; WONG, B. C. Y; LAM, S. K et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 3, pp 521-526, issn 0269-2813Article

Twenty-minute 50 mg ¹³C-urea breath test without test meal for the diagnosis of Helicobacter pylori infection in ChineseWONG, W. M; WONG, B. C. Y; LI, T. M et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 9, pp 1499-1504, issn 0269-2813Article

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infectionWONG, W. M; GU, Q; CHU, K.-M et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 3, pp 421-427, issn 0269-2813, 7 p.Article

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infectionWONG, W. M; GU, Q; WONG, B. C. Y et al.Alimentary pharmacology & therapeutics. 2003, Vol 17, Num 4, pp 553-560, issn 0269-2813, 8 p.Article

High prevalence of mixed infections by Helicobacter pylori in Hong Kong : metronidazole sensitivity and overall genotypeWONG, B. C. Y; WANG, W. H; BERG, D. E et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 4, pp 493-503, issn 0269-2813Article

Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers : a randomized controlled studyWONG, B. C. Y; WANG, W. H; LIU, X. G et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 6, pp 843-849, issn 0269-2813Article

One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in ChineseHUNG, W. K; WONG, W. M; FUNG, F. M. Y et al.Alimentary pharmacology & therapeutics. 2002, Vol 16, Num 12, pp 2067-2072, issn 0269-2813, 6 p.Article

Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infectionWONG, B. C. Y; WONG, W. M; LAI, K. C et al.Alimentary pharmacology & therapeutics. 2001, Vol 15, Num 12, pp 1959-1965, issn 0269-2813Article

¹³C-urea breath test without a test meal is highly accurate for the detection of Helicobacter pylori infection in ChineseWONG, W. M; WONG, B. C. Y; CHAN, C. K et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 10, pp 1353-1358, issn 0269-2813Article

High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong KongWANG, W. H; WONG, B. C. Y; MUKHOPADHYAY, A. K et al.Alimentary pharmacology & therapeutics. 2000, Vol 14, Num 7, pp 901-910, issn 0269-2813Article